| Literature DB >> 28428157 |
Sherif M Badawy1,2, Lisa M Kuhns3.
Abstract
BACKGROUND: Many preventable behaviors contribute to adolescent mortality and morbidity. Non-adherence to preventive measures represents a challenge and has been associated with worse health outcomes in this population. The widespread use of electronic communication technologies by adolescents, particularly the use of text messaging (short message service, SMS) and mobile phones, presents new opportunities to intervene on risk and preventive risk behavior, but little is known about their efficacy.Entities:
Keywords: adolescent; behavior; medication adherence; mobile applications; mobile phone; prevention; smartphone; text messaging
Year: 2017 PMID: 28428157 PMCID: PMC5415660 DOI: 10.2196/mhealth.6837
Source DB: PubMed Journal: JMIR Mhealth Uhealth ISSN: 2291-5222 Impact factor: 4.773
Figure 1Flow of studies through the review according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines.
Summary of included studies focused on improving adherence to preventive measures in adolescents.
| Source (country) | Aim of intervention | Study design (setting) | Age in years, (sex) | Group (n) | Tech | Follow-up | Retention rate | Grade |
| Narring et al [ | Improve attendance in clinic | RCT (randomized controlled trial), investigator-blinded (multidisciplinary youth clinic: primary care, gynecological and mental) | Interventiona: 17.7 (2.8) (75.9% Female) | Intervention (469) | Text messages | 6 months | Intervention: 462 (98.5%) | Moderate |
| Branson et al[ | Improve attendance in mental health clinic | Quasi-experimental pilot study (large hospital mental health clinic) | Interventiona: 15.4 (1.3) (58% Female) | Intervention (24) | Text messages | 3 months | Intervention: 24 (100%) | Moderate |
| Castano et al [ | Improve continuation of OCPs (oral contraceptive pills) | RCT, investigator-blinded (urban family planning health center) | Interventiona: 20.8 (2.5) | Intervention (480) | Text messages | 6 months | Intervention: 346 (72.1%) | Moderate |
| Hou et al[ | Increase adherence to OCPs | RCT, investigator-blinded (Planned Parenthood League clinic) | Interventionb: 22 (18-31) | Intervention (41) | Text messages | 3 months | Intervention: 36 (88%) | Moderate |
| Trent et al [ | Improving Depo-Provera appointment attendance | RCT, nonblinded (large urban academic General Pediatric and Adolescent Medicine Practice) | Interventionb: 13-21 | Intervention (50) | Text messages | 12 months | Intervention: 33 (66%) | High |
| Suffoletto et al [ | Reduce sex risk behavior among at-risk young adult Fg discharged from emergency department | RCT, nonblinded (urban tertiary hospital emergency department) | Interventiona: 22 (2) | Intervention (23) | Text messages | 3 months | Intervention: 15 (65%) | Low |
| Cornelius et al [ | Improve HIV knowledge and attitudes toward condoms among African American adolescents | Pre-post single-arm pilot study (university) | Interventiona: 15.4 (1.7) (52.5% Female) | Intervention (40) | Text messages | 3 months | Intervention: 36 (90%) | Low |
| Lopez et al [ | Provide sexual education and improve knowledge about the sexual risk factors | Pre-post single-arm pilot study (university) | Interventiona: 21 (3.6) (53% Female) | Intervention (127) | App | 6 months | Intervention: 58 (45.7%) | Very low |
| Moore et al [ | Reduce future alcohol consumption based on data of past alcohol expenditure | RCT, nonblinded (university) | Studenta: 22 (3.7) | Intervention (40): Student (21); nonstudent (19) | Text messages | 2 months | Intervention: Student 20 (95%); nonstudent 18 (95%) | Low |
| Haug et al [ | Reduce alcohol binge or problem drinking | Pre-post single-arm pilot study (vocational school) | Intervention “participants”a: 18.0 (2.4) (24.5% Female) | Intervention (364) | Text messages | 3 months | Intervention: 280 (76.9%) | Moderate |
| Haug et al [ | Increase smoking cessation and reduce cigarettes consumption | Two-arm cluster RCT, assessor-blinded (vocational school) | Interventiona: 18.2 (2.4) (48.7% Female) | Intervention (372) | Text messages | 6 months | Intervention: 287 (77.2%) | High |
| Zotti et al [ | Improve oral hygiene adherence and oral health | RCT, assessor-blinded (orthodontic clinic in a university hospital) | Interventiona: 14.1 (58% Female) | App (40) | App | 12 months | Intervention: 40 (100%) | Low |
| Bowen et al [ | Improve adherence to oral hygiene and reduce plaque formation | RCT, patient-blinded (orthodontic clinic in a university hospital) | Interventiona: 15.5 (60% Female) | Intervention (25) | Text messages | 3 months | Intervention: 19 (76%) | Low |
| Lau et al [ | Promote physical activity in school age children | Quasi-experimental (secondary schools) | Interventiona: 12.3 (0.9) (68% Female) | Intervention (38) | Text messages | 2 months | Intervention: 38 (100%) | Low |
| Abraham et al [ | Improve weight management | RCT, investigator-blinded (pediatric obesity clinic of a tertiary care hospital) | Intervention “Internet”b: 14.9, 13.7-16.2 (44% Female) | Intervention “Internet” (16) | Text messages | 6 months | Intervention “Internet”: 16 (100%) | Low |
| Pretlow et al [ | Improve weight management | Pre-post single arm pilot study (university hospital clinic and on the Internet) | Interventiona: 16 (0.43) | Intervention (43) | App | 5 months | Intervention: 27 (63%) | Moderate |
| Direito et al [ | Improve fitness in insufficiently active healthy young people | Three-arm, parallel, RCT, nonblinded (participants home) | Intervention “immersive”a: 15.78 (1.11) (53% Female) | Intervention “immersive” (17) | App | 2 months | Intervention “immersive”: 17 (100%) | Moderate |
| Sachse et al [ | Improve sun-protection knowledge and behavior | Pre-post single-arm pilot study (summer cap/clinic) | Interventiona: 16.1 y, 13-22 (27% Female) | Intervention (26) | Text messages | 2 months | Intervention: 19 (73%) | Very low |
| Matheson et al [ | Increase HPV (human papillomavirus) vaccination series completion rate | Pilot Quality Improvement project (urban pediatric clinic) | Interventiona: 12 (62% Female) | Intervention (37) | Text messages | 8 months | Intervention: data not reported | Low |
aAge reported as mean (SD, standard deviation).
bAge reported as median ( range, minimum-maximum).
cInterested group included patients or parents enrolled in the project during their clinic visit who did not complete their opt-in process to receive text message reminders after leaving clinic; historical control included all patients who initiated HPV vaccination series during study period, but were either not offered or declined to participate in the project.
dN/A: not applicable.
Effect sizes for the main outcomes of included studies.
| Source | Study outcomes | Effect size, | |
| Narring et al [ | Attendance to all clinics | 0.15 (–0.03 to 0.33) | |
| Attendance to primary care clinic | 0.06 (–0.16 to 0.27) | ||
| Attendance to gynecological clinic | 0.32 (–0.10 to 0.74) | ||
| Attendance to mental health clinic | 0.32 (–0.21 to 0.85) | ||
| Attendance to mental health clinic | 0.32 (–0.21 to 0.85) | ||
| Branson et al [ | Attendance to mental health clinic | 0.67 (0.09-1.25)h | |
| Castano et al [ | Continued use of OCPsb at follow-up: overall | 0.23 (0.06-0.40)h | |
| Continued use of OCPs at ≤187 days | 0.52 (0.19-0.86)h | ||
| Continued use of OCPs at ≥188 days | 0.13 (–0.07 to 0.33) | ||
| Hou et al [ | Decreased OCP doses miss rate: all participants | 0.09 (–0.34 to 0.53) | |
| Decreased OCP doses miss rate: 3 cycles complete | 0.13 (–0.30 to 0.57) | ||
| Trent et al [ | Depo-Provera on-time visit attendance: cycle 1 | 0.29 (–0.19 to 0.77) | |
| Depo-Provera on-time visit attendance: cycle 2 | 0.77 (–0.35 to 0.69) | ||
| Depo-Provera on-time visit attendance: cycle 3 | 0.01 (–0.57 to 0.60) | ||
| Suffoletto et al [ | Condom use with last sexual intercourse | 0.32 (–0.29 to 0.93) | |
| Always condom use in last 28 days | 0.29 (–0.38 to 0.95) | ||
| Drug or alcohol use before last sex | 0.23 (–0.53 to 0.99) | ||
| Any unprotected sex with concurrent alcohol use in last 28 days | 0.58 (–0.41 to 1.57) | ||
| Cornelius et al [ | HIV knowledge | 0.42 (–0.03 to 0.86) | |
| Attitudes toward condoms | 0.08 (–0.36 to 0.52) | ||
| Reduction in risky behavior: intercourse | 0.17 (–0.27 to 0.60) | ||
| Reduction in risky behavior: illegal drugs | 0.41 (–0.03 to 0.86) | ||
| Moore et al [ | Decrease alcohold use in students | 0.00 (–0.65 to 0.65) | |
| Decrease alcohol use in nonstudents | 0.13 (–0.48 to 0.75) | ||
| Haug et al [ | Reduction in RSODc in persons with ≥1 occasion in the last month | 0.22 (0.01- 0.42)h | |
| Reduction in RSOD in persons with >2 occasions in the last month | 0.16 (–0.02 to 0.35) | ||
| Reduction in number of standard drinks in a typical week | 0.14 (–0.02 to 0.31) | ||
| Reduction in the maximum number of drinks on an RSOD occasion | 0.08 (–0.09 to 0.24) | ||
| Reduction in having one or more alcohol-related problems | 0.24 (–0.01 to 0.48) | ||
| Haug et al [ | 7-day smoking abstinence at 6 months: total sample | 0.16 (–0.13 to 0.46) | |
| 7-day smoking abstinence at 6 months: occasional smokers | 0.25 (–0.21 to 0.71) | ||
| 7-day smoking abstinence at 6 months: daily smokers | 0.15 (–0.28 to 0.59) | ||
| 4-week smoking abstinence at 6 months: total sample | 0.08 (–0.31 to 0.47) | ||
| 4-week smoking abstinence at 6 months: occasional smokers | 0.38 (–0.27 to 1.03) | ||
| 4-week smoking abstinence at 6 months: daily smokers | 0.39 (–0.21 to 0.98) | ||
| Reduction in cigarette consumption at 6 months: total sample | 0.33 (0.16-0.50)h | ||
| Reduction in cigarette consumption at 6 months: occasional smokers | 0.36 (0.02-0.71)h | ||
| Reduction in cigarette consumption at 6 months: daily smokers | 0.20 (0.01-0.39)h | ||
| Smoking quit attempts at 6 months: total sample | 0.17 (–0.02-0.36) | ||
| Smoking quit attempts at 6 months: occasional smokers | 1.09 (0.65-1.52)h | ||
| Smoking quit attempts at 6 months: daily smokers | 0.06 (–0.16 to 0.29) | ||
| Zotti et al [ | Gingival index at 6 months | 0.56 (0.12-1.01)h | |
| Gingival index at 9 months | 1.04 (0.57-1.51)h | ||
| Gingival index at 12 months | 1.43 (0.94-1.92)h | ||
| Plaque index at 6 months | 0.73 (0.28-1.18)h | ||
| Plaque index at 9 months | 1.50 (1.00-2.00)h | ||
| Plaque index at 12 months | 1.40 (0.91-1.89)h | ||
| Visible white spots at 9 months | 0.67 (0.04-1.30)h | ||
| Visible white spots at 12 months | 0.63 (0.06-1.20)h | ||
| Bowen et al [ | Plaque coverage reduction at 4 weeks | 1.62 (0.98-2.26)h | |
| Plaque coverage reduction at 12 weeks | 2.40 (1.67-3.12)h | ||
| Lau et al [ | Self-report of physical activity | 0.31 (–0.14 to 0.76) | |
| Abraham et al [ | Reduction in BMI (body mass index ) | 0.09 (–0.61 to 0.78) | |
| Pretlow et al [ | Reduction in percent over-BMI in males | 0.17 (–0.55 to 0.88) | |
| Reduction in percent over-BMI in females | 0.08 (–0.44 to 0.61) | ||
| Direito et al [ | Time to complete 1-mile walk or run using an immersive app | –0.238 (–0.9 to 0.43) | |
| Time to complete 1-mile walk or run using a nonimmersive app | –0.14 (–0.81 to 0.54) | ||
| Sachse et al [ | Understanding of the meaning of UVf-index | 1.49 (0.61-2.37)h | |
| Naming ≥3 of ABCDE (ie, asymmetry, border, color, diameter, and evolution) mnemonic for skin self-exam | 1.40 (0.19-2.61)h | ||
| Knowing that it takes hours to recognize sunburns | 0.51 (–0.24 to 1.26) | ||
| Matheson et al [ | HPVg vaccine dose 2 | 1.10 (0.67-1.52)h | |
| HPV vaccine dose 2 on-time | 0.46 (0.06-0.86)h | ||
| HPV vaccine dose 3 | 0.70 (0.14-1.27)h | ||
| HPV vaccine dose 3 on-time | 0.91 (0.24-1.58)h | ||
aPositive effect size value means improvement in a study outcome, while a negative one means worsening outcome.
bOCPs: oral contraceptive pills.
cRSOD: risky single-occasion drinking.
dGingival index score (0-3): 0 being normal gingiva and 3 having severe inflammation and edema, with spontaneous bleeding; plaque index score (0-3): 0 being best with no plaques and 3 having plaque covering more than half of the surface; white spots score: (0-3): 0 being no visible white spots and 3 having visible white spots requiring restoration.
ePercent over-BMI was calculated as [(BMI – BMI at 50th percentile for age and sex) / BMI at 50th percentile] × 100.
fUV: ultraviolet.
gHPV: human papillomavirus.
hStatistically significant P<.05.